Wanchun Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wanchun Wang has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Yuanping Hao
Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao 266001, China
5 shared publications Zhe Zhang
Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao 266001, China
4 shared publicationsTingting Zhu
Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao, China
3 shared publicationsZhiqin Sang
Qingdao Stomatological Hospital Affiliated to Qingdao University, Qingdao, China
3 shared publications- Tingting Zhu
School of Stomatology of Qingdao University, Qingdao 266003, China
2 shared publications Xiaoli Guo
Department of Stomatology, School of Stomatology of Weifang Medical University, Weifang, China
2 shared publications
Latest Publications
- Open Access
- 12 March 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1751956
Associations between oral health problems and inflammatory bowel disease: evidence from prospective cohort study
Background: An association exists between oral health problems and inflammatory bowel disease (IBD). However, few studies have considered comprehensive oral health problems and the concurrent presence of multiple oral health problems in relation to IBD. Additionally, the role of inflammatory responses as a mediator in this relationship remains unexplored. This study aimed to investigate association between oral health problems and IBD utilizing data from the UK Biobank. Methods: Oral health were assessed via self-reported. IBD was defined by disease classification codes from the International Classification of Diseases-10. Cox regression models were employed to analyze the relationships between oral health problems and IBD, using mediation analysis to investigate the role and effect size of inflammatory indicators in this association. Results: Among 412,134 participants, mouth ulcers (HR: 1.25, 95% CI: 1.02-1.53), painful gums (HR: 1.50, 95% CI: 1.12-2.03), and dentures (HR: 1.30, 95% CI: 1.10-1.53) linked to Crohn’s disease (CD) risk. Mouth ulcers (HR: 1.16, 95% CI: 1.01-1.34) and dentures (HR: 1.18, 95% CI: 1.05-1.33) linked to ulcerative Colitis (UC) risk. Having two (HR: 1.29, 95% CI: 1.02-1.63)/three (HR: 1.69, 95% CI: 1.14-2.49)/more than three (HR: 2.13, 95% CI: 1.20-3.78) oral health problems correlated with CD risk, with more oral health problems correlating with higher CD risk (P for trend < 0.001). Low-grade inflammation index (INFLA-score) positively mediated the association between painful gums (proportion mediated=3.09%)/dentures (proportion mediated=5.40%) and CD. Conclusions: Mouth ulcers and dentures may increase the risk of CD and UC, while painful gums associates with CD. More oral health problems link to higher CD risk. Inflammatory responses partially mediating the association between painful gums/dentures and CD.
- 12 March 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1751956
Open AccessAssociations between oral health problems and inflammatory bowel disease: evidence from prospective cohort study
Background: An association exists between oral health problems and inflammatory bowel disease (IBD). However, few studies have considered comprehensive oral health problems and the concurrent presence of multiple oral health problems in relation to IBD. Additionally, the role of inflammatory responses as a mediator in this relationship remains unexplored. This study aimed to investigate association between oral health problems and IBD utilizing data from the UK Biobank. Methods: Oral health were assessed via self-reported. IBD was defined by disease classification codes from the International Classification of Diseases-10. Cox regression models were employed to analyze the relationships between oral health problems and IBD, using mediation analysis to investigate the role and effect size of inflammatory indicators in this association. Results: Among 412,134 participants, mouth ulcers (HR: 1.25, 95% CI: 1.02-1.53), painful gums (HR: 1.50, 95% CI: 1.12-2.03), and dentures (HR: 1.30, 95% CI: 1.10-1.53) linked to Crohn’s disease (CD) risk. Mouth ulcers (HR: 1.16, 95% CI: 1.01-1.34) and dentures (HR: 1.18, 95% CI: 1.05-1.33) linked to ulcerative Colitis (UC) risk. Having two (HR: 1.29, 95% CI: 1.02-1.63)/three (HR: 1.69, 95% CI: 1.14-2.49)/more than three (HR: 2.13, 95% CI: 1.20-3.78) oral health problems correlated with CD risk, with more oral health problems correlating with higher CD risk (P for trend < 0.001). Low-grade inflammation index (INFLA-score) positively mediated the association between painful gums (proportion mediated=3.09%)/dentures (proportion mediated=5.40%) and CD. Conclusions: Mouth ulcers and dentures may increase the risk of CD and UC, while painful gums associates with CD. More oral health problems link to higher CD risk. Inflammatory responses partially mediating the association between painful gums/dentures and CD.
- Open Access
- 22 October 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1613165
Decoding oral leukoplakia: microbiome dysbiosis and inflammatory dynamics unveiled in a rat model
Introduction: Oral leukoplakia (OLK) is an oral precancerous lesion associated with oral microbiome dysbiosis and systemic inflammation. However, the longitudinal changes of the microbiome and its causal relationship with inflammation remain unclear, and traditional sequencing struggles to detect low-biomass samples. Methods: A 4-nitroquinoline-1-oxide (4-NQO)-induced rat OLK model was used. The oral microbiome was analyzed via 2bRAD-M sequencing; serum levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were measured. Additionally, functional pathway analysis of the microbiome and its correlation with inflammation were conducted. Results: In OLK, we observed significant shifts in the oral microbial diversity, marked by elevated abundances of Streptococcus , Glaesserella , and Pseudomonas aeruginosa . Moreover, shifts in the microbiota precede the manifestation of clinical symptoms of OLK. Functional pathway analysis highlighted enrichment in metabolism, quorum sensing, and cancer-associated microRNA pathways. Serum levels of inflammatory markers (TNF-α and IL-6) were significantly elevated in OLK and significantly correlated with specific bacterial taxa. Discussion: This study demonstrates the utility of 2bRAD-M sequencing in overcoming traditional metagenomic limitations, offering a high-resolution view of microbiome dynamics in low-biomass environments such as the oral mucosa. These findings establish the oral microbiota as candidate early biomarkers for OLK screening and prevention, opening avenues for precision diagnostics and targeted therapies to mitigate cancer risk associated with OLK.
- 22 October 2025
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1613165
Open AccessDecoding oral leukoplakia: microbiome dysbiosis and inflammatory dynamics unveiled in a rat model
Introduction: Oral leukoplakia (OLK) is an oral precancerous lesion associated with oral microbiome dysbiosis and systemic inflammation. However, the longitudinal changes of the microbiome and its causal relationship with inflammation remain unclear, and traditional sequencing struggles to detect low-biomass samples. Methods: A 4-nitroquinoline-1-oxide (4-NQO)-induced rat OLK model was used. The oral microbiome was analyzed via 2bRAD-M sequencing; serum levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were measured. Additionally, functional pathway analysis of the microbiome and its correlation with inflammation were conducted. Results: In OLK, we observed significant shifts in the oral microbial diversity, marked by elevated abundances of Streptococcus , Glaesserella , and Pseudomonas aeruginosa . Moreover, shifts in the microbiota precede the manifestation of clinical symptoms of OLK. Functional pathway analysis highlighted enrichment in metabolism, quorum sensing, and cancer-associated microRNA pathways. Serum levels of inflammatory markers (TNF-α and IL-6) were significantly elevated in OLK and significantly correlated with specific bacterial taxa. Discussion: This study demonstrates the utility of 2bRAD-M sequencing in overcoming traditional metagenomic limitations, offering a high-resolution view of microbiome dynamics in low-biomass environments such as the oral mucosa. These findings establish the oral microbiota as candidate early biomarkers for OLK screening and prevention, opening avenues for precision diagnostics and targeted therapies to mitigate cancer risk associated with OLK.
- 7 September 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 245, 114216
A hyaluronic acid-based dissolving microneedle patch loaded with 5-aminolevulinic acid for improved oral leukoplakia treatment
- 7 September 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 245, 114216
A hyaluronic acid-based dissolving microneedle patch loaded with 5-aminolevulinic acid for improved oral leukoplakia treatment
- Open Access
- 5 May 2023
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 11
Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
Oral mucositis (OM) is the most common disease of the oral mucosa, which affects people’s daily production and life. Triamcinolone ointment is the common clinical drug for OM treatment. However, the hydrophobic properties of triamcinolone acetonide (TA) and the complex microenvironment of the oral cavity led to its low bioavailability and unstable therapeutic effects on ulcer wounds. Herein, dissolving microneedle patches (MNs) composed of mesoporous polydopamine nanoparticles (MPDA) loaded with TA (TA@MPDA), sodium hyaluronic acid (HA), and Bletilla striata polysaccharide (BSP) are prepared as the transmucosal delivery system. The prepared TA@MPDA-HA/BSP MNs exhibit well-arranged microarrays, high mechanical strength and fast solubility (®. TA@MPDA-HA/BSP MNs are shown to be their great potential as novel ulcer dressings for OM management.
- 5 May 2023
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 11
Open AccessMicroneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
Oral mucositis (OM) is the most common disease of the oral mucosa, which affects people’s daily production and life. Triamcinolone ointment is the common clinical drug for OM treatment. However, the hydrophobic properties of triamcinolone acetonide (TA) and the complex microenvironment of the oral cavity led to its low bioavailability and unstable therapeutic effects on ulcer wounds. Herein, dissolving microneedle patches (MNs) composed of mesoporous polydopamine nanoparticles (MPDA) loaded with TA (TA@MPDA), sodium hyaluronic acid (HA), and Bletilla striata polysaccharide (BSP) are prepared as the transmucosal delivery system. The prepared TA@MPDA-HA/BSP MNs exhibit well-arranged microarrays, high mechanical strength and fast solubility (®. TA@MPDA-HA/BSP MNs are shown to be their great potential as novel ulcer dressings for OM management.
- Open Access
- 20 April 2023
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 11
Hypoxia mitigation by manganese-doped carbon dots for synergistic photodynamic therapy of oral squamous cell carcinoma
Photodynamic therapy (PDT) is widely used for cancer treatment due to its non-invasive and precise effectiveness, however, hypoxia in the tumor microenvironment greatly limits the efficacy of photodynamic therapy. Compared with conventional photosensitizers, carbon dots (CDs) have great potential. Therefore, developing a water-soluble, low-toxicity photosensitizer based on CDs is particularly important, especially one that can enhance the photodynamic efficacy using the tumor microenvironment to produce oxygen. Herein, manganese-doped carbon dot (Mn-CDs, ∼2.7 nm) nanoenzymes with excellent biocompatibility were prepared by a solvothermal method using ethylenediaminetetraacetic acid manganese disodium salt hydrate and o-phenylenediamine as precursors. TEM, AFM, HR-TEM, XRD, XPS, FT-IR, ζ potential, DLS, UV-Vis, and PL spectra were used to characterize the Mn-CDs. Cancer resistance was assessed using the CCK-8 kit, calcein AM versus propidium iodide (PI) kit, and the Annexin V-FITC/PI cell apoptosis assay kit. The obtained Mn-CDs have excellent near-infrared emission properties, stability, and efficient 1O2 generation. Notably, the manganese doping renders CDs with catalase (CAT)-like activity, which leads to the decomposition of acidic H2O2in situ to generate O2, enhancing the PDT efficacy against OSCC-9 cells under 635 nm (300 mW·cm−2) irradiation. Thus, this work provides a simple and feasible method for the development of water-soluble photosensitizers with oxygen production, presenting good biosafety for PDT in hypoxic tumors.
- 20 April 2023
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 11
Open AccessHypoxia mitigation by manganese-doped carbon dots for synergistic photodynamic therapy of oral squamous cell carcinoma
Photodynamic therapy (PDT) is widely used for cancer treatment due to its non-invasive and precise effectiveness, however, hypoxia in the tumor microenvironment greatly limits the efficacy of photodynamic therapy. Compared with conventional photosensitizers, carbon dots (CDs) have great potential. Therefore, developing a water-soluble, low-toxicity photosensitizer based on CDs is particularly important, especially one that can enhance the photodynamic efficacy using the tumor microenvironment to produce oxygen. Herein, manganese-doped carbon dot (Mn-CDs, ∼2.7 nm) nanoenzymes with excellent biocompatibility were prepared by a solvothermal method using ethylenediaminetetraacetic acid manganese disodium salt hydrate and o-phenylenediamine as precursors. TEM, AFM, HR-TEM, XRD, XPS, FT-IR, ζ potential, DLS, UV-Vis, and PL spectra were used to characterize the Mn-CDs. Cancer resistance was assessed using the CCK-8 kit, calcein AM versus propidium iodide (PI) kit, and the Annexin V-FITC/PI cell apoptosis assay kit. The obtained Mn-CDs have excellent near-infrared emission properties, stability, and efficient 1O2 generation. Notably, the manganese doping renders CDs with catalase (CAT)-like activity, which leads to the decomposition of acidic H2O2in situ to generate O2, enhancing the PDT efficacy against OSCC-9 cells under 635 nm (300 mW·cm−2) irradiation. Thus, this work provides a simple and feasible method for the development of water-soluble photosensitizers with oxygen production, presenting good biosafety for PDT in hypoxic tumors.
- 16 December 2022
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 222, 113100
Betamethasone-loaded dissolvable microneedle patch for oral ulcer treatment
- 16 December 2022
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 222, 113100
Betamethasone-loaded dissolvable microneedle patch for oral ulcer treatment
- Open Access
- 22 March 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (4) , 686
Lidocaine-Loaded Hyaluronic Acid Adhesive Microneedle Patch for Oral Mucosal Topical Anesthesia
The pain and fear caused by direct local injection of anesthetic or the poor experience with surface anesthetic cream increase the difficulty of clinical treatment for oral diseases. To address this problem, a hyaluronic acid microneedle patch (Li-HAMNs) that consists of fast-dissolving lidocaine hydrochloride (LDC)-loaded tips and a wet-adhesive backing layer made of polyvinyl alcohol (PVA)/carboxymethylcellulose sodium (CMC-Na) was fabricated to explore its potential use in dental topical anesthesia. Li-HAMNs could puncture the stratum corneum with an insertion depth of about 279 μm in the isolated porcine oral mucosal. The fast-dissolving tips could release LDC to improve the patients’ convenience and compliance. Importantly, the backing layer, which has good adhesion ability and water-absorbing properties, could surmount the contraction and extension of oral masticatory muscles and the saliva scour. In the tail flick test, the topical anesthesia efficacy of the Li-HAMNs group was much better than clinical lidocaine cream (EMLA cream, LDC, 1.2 mg) in spite of a relatively lower LDC dose with Li-HAMNs (LDC, 0.5 mg). It is believed that the proposed adhesive microneedle patch could enhance transmucosal delivery of anesthetics and thus open a new chapter in the painless treatment of oral diseases.
- 22 March 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (4) , 686
Open AccessLidocaine-Loaded Hyaluronic Acid Adhesive Microneedle Patch for Oral Mucosal Topical Anesthesia
The pain and fear caused by direct local injection of anesthetic or the poor experience with surface anesthetic cream increase the difficulty of clinical treatment for oral diseases. To address this problem, a hyaluronic acid microneedle patch (Li-HAMNs) that consists of fast-dissolving lidocaine hydrochloride (LDC)-loaded tips and a wet-adhesive backing layer made of polyvinyl alcohol (PVA)/carboxymethylcellulose sodium (CMC-Na) was fabricated to explore its potential use in dental topical anesthesia. Li-HAMNs could puncture the stratum corneum with an insertion depth of about 279 μm in the isolated porcine oral mucosal. The fast-dissolving tips could release LDC to improve the patients’ convenience and compliance. Importantly, the backing layer, which has good adhesion ability and water-absorbing properties, could surmount the contraction and extension of oral masticatory muscles and the saliva scour. In the tail flick test, the topical anesthesia efficacy of the Li-HAMNs group was much better than clinical lidocaine cream (EMLA cream, LDC, 1.2 mg) in spite of a relatively lower LDC dose with Li-HAMNs (LDC, 0.5 mg). It is believed that the proposed adhesive microneedle patch could enhance transmucosal delivery of anesthetics and thus open a new chapter in the painless treatment of oral diseases.